This page defines the modelling rules and description templates for Phase 1 only of the Canadian Medicines Terminology (CMT) project. Phase-specific content will be added as the project progresses.

Definition

The representation of a medicinal product supplied by a single organization (supplier) in Canada under a single product name, and which contains the same set of active ingredients and dose form. The active ingredients used to define a TMPF do not include any modification that is not either clinically significant or (if relevant) part of the product’s basis of strength substance.

Attributes

The TMPF uses the following defining attributes:

Attribute

Alias

Group

Card

G Card

D/O

Range

373873005 |Count of base of active ingredient|

BCount

NO

1..1

0..0

DATA

Integer >#0..

127489000 |Has active ingredient|

AI

YES (1)

0..*

0..1

OBJECT

< 105590001 |Substance|

762949000 |Has precise active ingredient

PAI

YES (1)

0..*

0..1

OBJECT

< 105590001 |Substance|

732943007 |Has basis of strength substance|

BOSS

YES (1)

0..*

0..1

OBJECT

< 105590001 |Substance|

411116001|Has manufactured dose form|

MDF

NO

0..1

0..0

OBJECT

< 736542009 |Pharmaceutical dose form|

774167006 |Product name|

ProdName

NO

0..1

0..0

OBJECT

< 774167006 |Product name|

774164004 |Supplier|

Supplier

NO

0..1

0..0

OBJECT

< 774164004 |Supplier|

Concepts

Up to two TMPF concepts are created for each DPD drug product. These are listed below.

TMPF-1 (mandatory)

The first TMPF concept must always be created (unless it already exists) for every DPD drug product and is defined using the following attributes:

Attribute

Alias

Group

Card

G Card

D/O

Range

373873005 |Count of base of active ingredient|

BCount

NO

1..1

0..0

DATA

Integer >#0..

127489000 |Has active ingredient|

AI

YES (1)

0..*

0..1

OBJECT

< 105590001 |Substance|

411116001|Has manufactured dose form|

MDF

NO

0..1

0..0

OBJECT

< 736542009 |Pharmaceutical dose form|

774167006 |Product name|

ProdName

NO

0..1

0..0

OBJECT

< 774167006 |Product name|

774164004 |Supplier|

Supplier

NO

0..1

0..0

OBJECT

< 774164004 |Supplier|

TMPF-2 (optional)

The second TMPF concept will only be created (unless it already exists) for each DPD drug product when:

BCount = 1 AND [0..0] TCD.BMCount (i.e. does not exist) AND BOSS <> AI

(i.e. single ingredient and BOSS <> AI)

and is defined using the following attributes:

Attribute

Alias

Group

Card

G Card

D/O

Range

373873005 |Count of base of active ingredient|

BCount

NO

1..1

0..0

DATA

Integer >#0..

762949000 |Has precise active ingredient

PAI

YES (1)

0..*

0..1

OBJECT

< 105590001 |Substance|

732943007 |Has basis of strength substance|

BOSS

YES (1)

0..*

0..1

OBJECT

< 105590001 |Substance|

411116001|Has manufactured dose form|

MDF

NO

0..1

0..0

OBJECT

< 736542009 |Pharmaceutical dose form|

774167006 |Product name|

ProdName

NO

0..1

0..0

OBJECT

< 774167006 |Product name|

774164004 |Supplier|

Supplier

NO

0..1

0..0

OBJECT

< 774164004 |Supplier|

 Descriptions

TMPF generation of en-CA Fully Specified Name (FSN)

Format

TMPF-1 (mandatory)

[[ + @ProdName]]1 “ [“ [[ + @AI]]“ ” [[ + @MDF ]] “ ] (” [[ + @Supplier]]2 “) (real medicinal product form)” 3

TMPF-2 (optional)

[[ + @ProdName]]1 “ [“ [[ + @PAI 5 OR @BOSS 6]] [ “ (as ” [[ + @PAI ]] “)”] 5  “ ” [[ + @MDF ]] “ ]   (” [[ + @Supplier]] 2 “) (real medicinal product form)” 3

TMPF generation of en-CA Preferred Term (PT)

Format

TMPF-1 (mandatory)

[[ + @ProdName]]1 “ [“ [[ + @AI]] “ ” [[ + @MDF ]] “ ] (” [[ + @Supplier]] 2 “)"4

TMPF-2 (optional)

[[ + @ProdName]]1 “ [“ [[ + @PAI 5 OR @BOSS 6]] [ “ (as ” [[ + @PAI ]] “)”] 5  “ ” [[ + @MDF ]] " ] (” [[ + @Supplier]] 2 “)" 4

Rules for English descriptions

1: ProdName is always fully capitalized

2: Supplier is always fully capitalized

3: For all attribute values, use the en-CA FSN with no semantic tag

4: For all attribute values, use the en-CA PT

5: PAI is used here when:

  1. BOSS is a modification of AI (direct or transitive)
    1. Note: In these cases, the PAI = TCD.BOSS

6: “BOSS (as PAI)” is used here when:

  1. BOSS is NOT a modification of AI (direct or transitive)

TMPF generation of fr-CA Fully Specified Name (FSN)

Format

TMPF-1 (mandatory)

[[ + @ProdName]]1 “ [“ [[ + @AI]]  “ ” [[ + @MDF ]] “ ] (” [[ + @Supplier]] 2 “) (forme du produit médicinal commercial)”3

TMPF-2 (optional)

[[ + @ProdName]]1 “ [“ [[ + @PAI 5 OR @BOSS 6]] [ “ ( ” [[ + @PAI ]] “)”] 5“ ” [[ + @MDF ]] " ] (” [[ + @Supplier]] 2 “) (forme du produit médicinal commercial)” 3

TMPF generation of fr-CA Preferred Term (PT)

Format

TMPF-1 (mandatory)

[[ + @ProdName]]1 “ [“ [[ + @AI]]  “ ” [[ + @MDF ]] “ ] (” [[ + @Supplier]] 2 “)” 4

TMPF-2 (optional)

[[ + @ProdName]]1 “ [“ [[ + @PAI 5 OR @BOSS 6]] [ “ ( ” [[ + @PAI ]] “)”] 5“ ” [[ + @MDF ]] " ] (” [[ + @Supplier]] 2 “)” 4

Rules for French descriptions

1: ProdName is always fully capitalized

2: Supplier is always fully capitalized

3: For all attribute values, use the fr-CA FSN with no semantic tag

4: For all attribute values, use the en-CA PT

5: PAI is used here when:

  1. BOSS is a modification of AI (direct or transitive).
    1. Note: In these cases the PAI = TCD.BOSS

6: “BOSS (as PAI)” is used here when:

  1. BOSS is NOT a modification of AI (direct or transitive)

Examples of TMPFs

 

TMPF-1

TMPF-2